Author Archive

BRIAN MECH • VP Business Development, Second Sight, Sylmar CA

Friday, February 15th, 2013

GREGOIRE COSENDAI • Vice President Europe. Second Sight, Lausanne Switzerland

“Michael O’Rourke of Scotia Vision Consultants was hired as a sales and marketing consultant to help with the launch of our new innovative ophthalmic technology Argus ll, both in Europe and the USA.Michael provided excellent insights into the global retinal market place with an emphasis on strategy. We will continue to use Michael & Scotia Vision as we further develop our global launch plans for this innovative and disruptive technology.With Michael’s extensive global product launch experience in Ophthalmology in both medical device and pharma, plus his specialization in retina and drug delivery, we would have no hesitation in recommending Michael to any potential clients looking to perfect their product launch and strategy development process.”

Is Increasing Drug Solubility The Answer To Improving Topical Eye Drug Delivery?

Wednesday, January 23rd, 2013

Improving the Delivery of Topical Ocular Drops

Using semifluorinated alkanes to transform poorly soluble drugs into effective therapeutics.


Novaliq GmbH, based in Heidelberg, Germany, is a drug delivery company that is developing a superior generation of ocular formulations for poorly soluble drugs. The patented ocular formulations are based on semifluorinated alkanes (SFAs), which can be easily applied in the form of eye drops or an eye spray.

Since its establishment in 2007, Novaliq has obtained four rounds of funding totalling €13.2 million from its major shareholder, Dievini Hopp Biotech Holding (a venture capital company focusing on biopharmaceutical companies in Europe). This funding is anticipated to support the company until 2015.


Click here to read the complete item. (PDF, 136 KB)

Scotia Vision Founder Michael O’Rourke presents at the 2011 annual “Controlled Release Society” meeting on “Market Development Strategies For Ocular Drug Delivery Systems”

Thursday, September 29th, 2011

“Ocular drug delivery is one of the most challenging endeavors due to the unique anatomy and physiology of the eye. This focus group will provide a forum for scientists from both industry and academia to share experiences, communicate lessons learned, and exchange information regarding novel biomaterials, formulations, delivery technologies, ocular pharmacokinetics and pharmacodynamics, and regulatory issues related to the development of ocular drug delivery systems. The mission of the focus group is to facilitate the understanding of key factors that influence and key issues that hinder effective drug delivery to the target tissues of the eye. The Ocular Drug Delivery Focus Group was established in April 2011.”

For more details visit:

For details contact Michael O’Rourke

ANGELA COLLIER • Senior Executive – International Networks, Scottish Enterprise

Thursday, September 29th, 2011

“Michael O’Rourke, a GlobalScot and founder of USA based Scotia Vision Consultants, met with 14 Scottish Life Science companies during a recent trip to Glasgow, Scotland. “GlobalScot” is a Scottish Government initiative that networks global expatriate Scots with home based companies, offering business advice and connections in markets across the world.

Michael researched each company in advance, reviewed business plans, discussed and offered input to their strategies and provided direction for moving their businesses forward, including in some cases the potential to develop their technologies for the USA. Following a feedback survey conducted by the GlobalScot team at Scottish Enterprise (SE) on the quality of advice received from Michael, all companies were overwhelmingly positive and stated their expectations had either been met or exceeded.

The GlobalScot team look forward to continuing their working relationship with Michael in his GlobalScot role advising Scottish Life Science organisations.”

CLIVE G WILSON, F.A.P.S.(Hons), F.C.R.S. • J P Todd Professor of Pharmaceutics, President, European Federation for Pharmaceutical Sciences. Strathclyde University, Scotland.

Thursday, September 29th, 2011

“I worked with Michael on an initiative in ocular drug delivery for the “Controlled Release Society”, although I knew him from his Bausch & Lomb days. He is a solid and engaging commercial expert and scientist with a passion for drug delivery.”

ALASTAIR KNOX • Founder & Director, Viopti, Scotland

Wednesday, April 13th, 2011

“I was first introduced to GlobalScot Michael of Scotia Vision during an introductory meeting set up by Scottish Enterprise International Networks in 2010. The meeting was to see how Scotia Vision could provide feedback for Viopti that was established in 2009 to provide a range of innovative contact lens eye care products for the contact lens user.

With Michael’s portfolio of knowledge and years of experience within the eye care industry his opinions could only be of value to Viopti. During the first meeting under NDA’s we both shared backgrounds and business ideas and from day one.

Michael has given feedback regarding Viopti’s business in areas such as product range, market potential, brand strategy, market research and discussing Viopti with leading ophthalmic specialists within the USA.

Along side feedback Michael has provided a huge amount of encouragement that has been of huge help to Viopti and myself personally. I regard Michael as a true professional and wish to keep open our communication across the channel for many years to come.”


Wednesday, February 23rd, 2011

Scotia Vision LLC website is hosted by a secure web hosting platform.

We will never sell, trade or rent any customer e-mail address or personal information to any third party. Nor will we share this information with any third party, except to the extent necessary to fulfill an order or when the outside party is strictly acting on our behalf with no independent right to use the information we provide.

Michael J. O’Rourke
Scotia Vision Consultants LLC
1027 South Dakota Ave, Tampa 33606 FL

813 323 1438 (Cell) 813 254 5777 (Office)


JASON WOODY • CEO Lions Eye Institute for Transplant & Research, Tampa FL

Friday, February 11th, 2011

“Michael is a hard-working consultant who invariably understands exactly what the customer’s objective is all about from the outset, and how to get it done in a quick and effective manner. During his six month consultancy we have seen truly amazing transitions in our program. Michael has consistently developed high revenue producing projects, which most were novel concepts never presented in a non-profit environment. Michael is a resourceful, creative, and solution-oriented person who was frequently able to come up with new and innovative approaches to his role as a consultant. Michael was well respected by our internal team. On the interpersonal side, Michael has extraordinary presentation and verbal communication skills. I have found him highly respected, as both a person and a professional, by all colleagues and previous employers. In closing, as detailed above, based on my experience working with Michael will be an asset to any organization that chooses to engage him.”

RANDY FREY • CEO LensAR, Winter Park FL

Tuesday, February 8th, 2011

“During Michael’s 12 month global consulting role with LensAR; he developed and led the LensAR company brand strategy for our disruptive femtosecond laser technology. He created a strategic communications and customer pre-launch awareness plan that created high value and respect for our company within the market. He also initiated multiple programs including market research that progressed the development of our launch program in this breakthrough area of ophthalmology. I would have no hesitation recommending Michael and Scotia Vision for your business challenges.”

MONTY ALLEN • CFO LensAR, Winter Park FL

Tuesday, February 8th, 2011

“As an early stage, single product, med device company, sales and marketing is the last thing that gets resourced and Michael got this effort going for us at LensAR.  He brings intense focus to building the brand, the annuity that any business needs for sustenance. Michael also reached out to the venture and IB community to present the market space during fund raisings.”